Advertising for brand-name drugs influences patients to prefer expensive options over equally effective generics, driving up costs and distorting medical decisions-even when doctors know the generic is just as good.
View more
Bioequivalence studies must now account for age and sex differences to ensure generic drugs work safely for everyone. Learn how regulators are changing rules and why older adults and women are finally being included.
View more
Drug patents are often said to last 20 years, but in reality, most drugs have only 7-12 years of market exclusivity due to lengthy approval times. Learn how patent extensions, regulatory exclusivity, and layered protections affect when generics become available.
View more
